Negócios em Emersão  ·  Vamos Emergir?  ·  Cadastre-se e ganhe 50 REC de bonus
Notícias

Acompanhe as Notícias da Recifes

Fique por dentro das últimas novidades sobre tecnologia, negócios e empreendedorismo.

12 resultados carregados na pagina 6 para "treat"
Study points to new target for treating aggressive brain cancer
Study points to new target for treating aggressive brain cancer
Glioblastoma remains one of the deadliest cancers, with limited treatment advances and tumors that often resist radiation and chemotherapy. New research from The Ohio State University Comprehensive Cancer Center–Arthur G. James Cancer Hospital and Richard J. Solove Research Insti
Foto: Vika Glitter / Pexels
Fluoxetine treatment after traumatic injury linked to fewer PTSD symptoms, lower pain
A preliminary, unblinded study has shown that people who took the antidepressant Prozac after suffering a traumatic injury reported fewer PTSD symptoms and lower levels of pain in the year after their injury.
Foto: Daniel Dan / Pexels
Doravirine works as well as dolutegravir to suppress HIV viral load, study finds
If you're a Black, 34-year-old South African woman living with HIV, antiretroviral (ARV) treatment options have likely been limited to tenofovir disoproxil fumarate (TDF), lamivudine (3TC) and the "gold standard," dolutegravir (DTG). Now, another once-daily, three-drug regimen ha
Foto: Alexas Fotos / Pexels
Emotion regulation therapy may help reduce problem alcohol use
A new treatment designed to improve emotional regulation in people with alcohol use disorder may help them drink less often. In a study of people receiving cognitive behavioral therapy (CBT) for alcohol use disorder, those who also received emotion regulation treatment had a grea
Foto: Tima Miroshnichenko / Pexels
AI creates psychiatry training cases, but human oversight remains essential
As the use of artificial intelligence for mental health conditions grows among both patients seeking support and psychiatrists treating them, West Virginia University researchers put ChatGPT-5 Pro to the test to determine its abilities in psychiatry education.
First-in-class small molecule inhibitor shows promise against pancreatic cancer in preclin
First-in-class small molecule inhibitor shows promise against pancreatic cancer in preclin
Mayo Clinic researchers have developed an experimental drug with the help of artificial intelligence (AI) to target the "undruggable" PDZ domain of the GIPC1 protein, which helps different types of cancer, including pancreatic cancer, grow and resist treatment. In laboratory stud
Foto: Diana ✨ / Pexels
New psychedelic candidate may spare the gut while still healing the brain
Psychedelic drugs are best known for altering perception and producing vivid hallucinations, but scientists are increasingly interested in what else they might do. A growing body of research suggests that these mind-altering substances could hold real promise as treatments for me
Foto: CP Khanal / Pexels
Fridge-free tetanus-diphtheria vaccine shows promise of reaching millions worldwide
The encouraging results of the world's first trial of a fridge-free tetanus-diphtheria vaccine could improve access worldwide to crucial treatments while reducing carbon emissions. Fridge-free vaccines have the potential to transform vaccine delivery by reducing dependence on ref
Foto: hartono subagio / Pexels
Aberrant protein activity rewires lymphoma cells to survive BTK inhibitors, offering targe
A protein that can dial down oxidative stress in cells helps some cancers resist treatment with a widely used class of drugs called BTK inhibitors, according to a study led by investigators at Weill Cornell Medicine. The discovery points to a possible solution to the problem of B
Systemic gap in drug subsidies leaves low-income pregnant women with fewer treatment optio
Systemic gap in drug subsidies leaves low-income pregnant women with fewer treatment optio
Pregnant women in Australia are facing an unfair two-tiered system for managing morning sickness, with financial status affecting who can access the full range of modern anti-nausea medications available rather than simply clinical need.
Most people with atypical Alzheimer's may be ineligible for new therapies
Most people with atypical Alzheimer's may be ineligible for new therapies
Many people with less common forms of Alzheimer's disease may not qualify for newer anti-amyloid treatments designed to slow the disease, according to a study published Aug. 5, 2026, in Neurology.
Foto: Amanda Kevin / Pexels
FLT3 inhibitors trigger ferroptosis, exposing new weakness in acute myeloid leukemia
A study published in Nature Cell Biology reports a new vulnerability in acute myeloid leukemia (AML) that might lead to novel therapies to treat the cancer while minimizing harm to normal cells. Researchers at Baylor College of Medicine and collaborating institutions studied a ne